Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA (Gliolan) fluorescence to label infiltration zones in meningiomas
2013-003230-32Phase 2Terminated
- Sponsor
- Medical University of Graz
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in meningioma, sponsored by Medical University of Graz. Primary endpoint: Positive fluorescence in malignant meningioma cells. Started Oct 2015; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
meningioma
Beyond the preview
Go deeper on 2013-003230-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003230-32.